The WACC of Sorrento Therapeutics Inc (SRNE) is 7.2%.
Range | Selected | |
Cost of equity | 13.20% - 39.00% | 26.10% |
Tax rate | 0.60% - 1.60% | 1.10% |
Cost of debt | 4.00% - 7.00% | 5.50% |
WACC | 4.8% - 9.6% | 7.2% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 2.03 | 6.1 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 13.20% | 39.00% |
Tax rate | 0.60% | 1.60% |
Debt/Equity ratio | 10.7 | 10.7 |
Cost of debt | 4.00% | 7.00% |
After-tax WACC | 4.8% | 9.6% |
Selected WACC | 7.2% | |